FS KKR Capital Corp. has given back some of its recent rally, slipping 2.8% on the week to $11.91, as the lending market shows early signs of renewed pressure — reversing part of the dramatic unwinding covered just days ago.
The most notable development is in availability, which has tightened back to 50.8% from 76.9% on August 14. That's a 21% deterioration in a single week, and it matters because this borrowing pool was virtually frozen as recently as late July — availability touched 0.56% on July 23. The prior note described a sharp exit by short sellers that freed up supply and compressed costs. That exit has stalled. Estimated short shares rose 3.1% on the day to 13.4 million, clawing back some of the ground lost during the week-long unwinding. Cost to borrow, while still much lower than the 4.9% peaks of late July, has ticked back up to 1.72% — though it remains down 61% over the past month, so the broader trend still points to a looser market than a few weeks ago. The ORTEX short score has edged up to 61.0, its highest reading of the past ten days, suggesting the brief cooling in bearish conviction may be fading.
Options positioning remains notably calm against this backdrop. The put/call ratio of 0.58 is barely above its 20-day average of 0.58, with a z-score close to zero — meaning options traders are not pricing in directional stress. That contrasts sharply with the 52-week high PCR of 2.49, which reflected a period of heavy downside hedging. Right now the options market is quiet, which sits in some tension with the renewed tightening in the borrow pool.
The Street's reaction to Q2 results is instructive. JP Morgan raised its target from $9.50 to $11.00 just yesterday while keeping a Neutral rating — a directional upgrade in conviction even without a ratings change. RBC Capital and Truist Securities both lifted targets earlier this month, to $13.00 and $12.00 respectively, also from Hold-equivalent positions. The pattern is consistent: analysts are marking up numbers after the earnings beat, but none are willing to turn constructive. The mean target sits near $11-13 across recent movers, broadly in line with the current price, suggesting limited implied upside from the Street. The bull case rests on FSK's middle-market income generation and leverage discipline; the bear case centres on non-accruals hitting 5.3% of the portfolio in Q2 — up from 3.5% the prior quarter — and NAV per share printing roughly 6% below estimates at $21.93. The P/B multiple has re-rated meaningfully, rising 0.10x over the past 30 days to 0.67x, reflecting the stock's one-month rebound of nearly 9%, but it still trades at a material discount to book, which is the core tension the market is pricing.
Among close peers, BCSF fell 6.0% on the week and NMFC dropped 3.6%, suggesting FSK's 2.8% decline is not isolated — BDC sentiment has broadly softened. TCPC bucked the trend with a 4.6% weekly gain, while ARCC held in better, down just 1.5%. The divergence hints that credit-quality differentiation is driving returns within the sector rather than a macro tide lifting or sinking all boats.
The borrow market is the variable to watch: whether availability continues tightening back toward the sub-5% levels seen in late July, or stabilises around current levels, will likely dictate whether the Q2 earnings relief rally has more to run before the next event window opens on November 6.
See the live data behind this article on ORTEX.
Open FSK on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
